Cover image not available

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor : a systematic review and economic evaluat

Publication Data

Title Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor : a systematic review and economic evaluat
Contributors K. Malottki, NIHR Evaluation, Trials and Studies Coordinating Centre, NIHR Health Technology Assessment Programme
Publisher Prepress Projects Ltd. on behalf of NETSCC, HTA
Publication date 2011
Publication location Perth
Language English

Topics

Rheumatoid arthritis :: Treatment :: Economic aspects
Antirheumatic agents :: Testing

Catalogue Data

OBNB ID GBB163150
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.72270610724

ISBD

P1053 xvii, 278 p.
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor : a systematic review and economic evaluat. Published by Prepress Projects Ltd. on behalf of NETSCC, HTA in 2011. Publication and catalogue information, links to buy online and reader comments.